Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study.

García-Álvarez M, Berenguer J, Jiménez-Sousa MA, Pineda-Tenor D, Aldámiz-Echevarria T, Tejerina F, Diez C, Vázquez-Morón S, Resino S.

Sci Rep. 2017 Jan 31;7:41516. doi: 10.1038/srep41516.

2.

A novel anti-viral role for STAT3 in IFN-α signalling responses.

Mahony R, Gargan S, Roberts KL, Bourke N, Keating SE, Bowie AG, O'Farrelly C, Stevenson NJ.

Cell Mol Life Sci. 2017 May;74(9):1755-1764. doi: 10.1007/s00018-016-2435-3. Epub 2016 Dec 17.

PMID:
27988795
3.

Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus.

Domagalski K, Pawłowska M, Zaleśna A, Pilarczyk M, Rajewski P, Halota W, Tretyn A.

World J Gastroenterol. 2016 Nov 7;22(41):9186-9195.

4.

Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.

Shrivastava S, Meissner EG, Funk E, Poonia S, Shokeen V, Thakur A, Poonia B, Sarin SK, Trehanpati N, Kottilil S.

Hepatol Int. 2016 Nov;10(6):937-946. Epub 2016 May 18.

PMID:
27193023
5.

Biology of Zika Virus Infection in Human Skin Cells.

Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, Perera-Lecoin M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau VM, Choumet V, Briant L, Desprès P, Amara A, Yssel H, Missé D.

J Virol. 2015 Sep;89(17):8880-96. doi: 10.1128/JVI.00354-15. Epub 2015 Jun 17.

6.
7.

Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.

Lind K, Svedin E, Utorova R, Stone VM, Flodström-Tullberg M.

Clin Exp Immunol. 2014 Sep;177(3):687-95. doi: 10.1111/cei.12368.

8.

Association between polymorphisms in OAS2 and CD209 genes and predisposition to chronic hepatitis C in Russian population.

Barkhash AV, Kochneva GV, Chub EV, Mikhailova SV, Romaschenko AG.

Microbes Infect. 2014 May;16(5):445-9. doi: 10.1016/j.micinf.2014.02.004. Epub 2014 Mar 1.

PMID:
24594345
9.

Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV.

Flores MV, Hickling TP, Sreckovic S, Fidock MD, Horscroft N, Katragadda M, Savic B, Rawal J, Delpuech-Adams OE, Robas N, Corey T, Nelms L, Lawton M, Marcek J, Stubbs M, Westby M, Ciaramella G.

Antivir Ther. 2012;17(5):869-81. doi: 10.3851/IMP2099. Epub 2012 Apr 13. Erratum in: Antivir Ther.2012;17(5):939.

PMID:
22505586
10.

Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.

Felger JC, Cole SW, Pace TW, Hu F, Woolwine BJ, Doho GH, Raison CL, Miller AH.

Psychol Med. 2012 Aug;42(8):1591-603. doi: 10.1017/S0033291711002868. Epub 2011 Dec 9.

11.

Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.

Minisini R, Giarda P, Grossi G, Bitetto D, Toniutto P, Falleti E, Avellini C, Occhino G, Fabris C, Pirisi M.

J Gastroenterol. 2011 Nov;46(11):1307-15. doi: 10.1007/s00535-011-0440-8. Epub 2011 Jul 23.

PMID:
21789480
12.

Polymorphisms of interferon-inducible genes OAS associated with interferon-α treatment response in chronic HBV infection.

Ren S, Yu H, Zhang H, Liu Y, Huang Y, Ma L, Wei L, Wu H, Chen X.

Antiviral Res. 2011 Mar;89(3):232-7. doi: 10.1016/j.antiviral.2011.01.006. Epub 2011 Jan 28.

PMID:
21277331
13.

Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression.

Kulka M, Calvo MS, Ngo DT, Wales SQ, Goswami BB.

Virology. 2009 May 25;388(1):169-84. doi: 10.1016/j.virol.2009.03.014. Epub 2009 Apr 19.

14.

Ability of peripheral blood mononuclear cells to activate interferon response in vitro is predictive of virological response in HCV patients.

Lalle E, Calcaterra S, Horejsh D, Abbate I, D'Offizi G, Abdeddaim A, Vlassi C, Antonucci G, Capobianchi MR.

J Biol Regul Homeost Agents. 2008 Jul-Sep;22(3):153-60.

PMID:
18842168
15.
16.

[The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].

Jia YT, Wei L, Jiang D, Cong X, Fei R.

Zhonghua Gan Zang Bing Za Zhi. 2006 Jan;14(1):7-10. Chinese.

PMID:
16420756
17.

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

Bièche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M.

Virology. 2005 Feb 5;332(1):130-44.

Supplemental Content

Loading ...
Support Center